ArticleCancer chemotherapy and pharmacology2021

Phase I study of liposomal irinotecan (LY01610) in patients with advanced esophageal squamous cell carcinoma.

Yun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.